BlackRock Capital Allocation Trust (BCAT) is a strategically managed investment vehicle tailored for institutional investors, featuring a diversified portfolio that spans global equities and fixed-income markets. Leveraging BlackRock's extensive market insights and research capabilities, BCAT employs a dynamic investment strategy designed to optimize capital allocation across various asset classes, allowing for agile responses to changing market conditions. This strategic flexibility positions the trust to deliver sustainable income and long-term capital appreciation, making it an appealing option for investors seeking to enhance risk-adjusted returns and achieve comprehensive portfolio diversification.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | 5.63 |
| EV/Revenue | 5.65 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $107.02M |
| Float | 0 |
| % Insiders | 0.05% |
| % Institutions | 18.32% |
Volatility is currently expanding
BlackRock Capital Allocation Term Trust expects to issue about 3.3 million new shares at $13.30, 98.5% of NAV, raising about $43 million in its 1-for-5 rights offering. Only about 15.5% of the 21.3 million shares on offer were taken up, because the subscription price was just 0.6% below the market price at expiry. NAV dilution was tiny at roughly -0.05%, and BlackRock paid all the offering expenses.
CEFs fell this week: 4 of 26 sectors rose on price (average -0.90%) and 8 of 26 on NAV (average -0.20%); munis held up while commodities lagged. HERZ's tender for 5% of its shares at 97.5% of NAV drew 71% participation, so only about 7% of tendered shares were accepted, worth about +1.4% on a full position. At the fund level, HQH (+6.80%) led on price and OCCI (-17.42%) fell the most, while THW (+5.18%) led on NAV and ASA (-5.78%) declined the most.
NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.
CEFs fell this week: 7 of 26 sectors rose on price (average -0.88%) and 12 of 26 on NAV (average -0.30%); munis led while convertibles lagged. DMA announced a buyback and +2.2% distribution raise as it entered its term measurement period; ASGI's rights offering was about 34% subscribed at $19.28. At the fund level, NMS (+5.11%) led on price and KF fell the most (-15.39%); on NAV, BGR (+4.62%) led while KF dropped -16.09%.
NEW YORK--(BUSINESS WIRE)---- $BCAT--BlackRock Capital Allocation Term Trust (NYSE: BCAT) (the "Fund") today announced the successful completion of its transferable rights offer (the “Offer”) which expired on October 21, 2026 (the “Expiration Date”). The Offer entitled rights holders to subscribe for up to an aggregate of 21,255,200 shares of the Fund's common stock, par value of $0.001 per share (each, a “Common Share”). The final subscription price of $13.30 per Common Share was determined based upon t.
NEW YORK--(BUSINESS WIRE)---- $BCAT--The BlackRock closed-end funds (the “Funds”) listed below announced today the results of the Measurement Period (as defined below) under their previously announced discount management programs (the “Programs”). Under the Programs, if a Fund's common shares trade at an average daily discount to net asset value ("NAV") of greater than 10.00% during the 9-month measurement period (the "Measurement Period"), the Fund intends to offer to repurchase, as soon as practicable.
BlackRock Capital Allocation Term Trust announced a rights offering with a conservative 1-for-5 ratio and a 98.5% NAV floor. The subscription price is set at 95% of market price, capped at $0.01 below NAV, minimizing dilution to a worst-case ~-0.25%. BCAT's premium compressed sharply post-announcement, highlighting the risk of holding CEFs at elevated premiums ahead of offerings.
A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV. But there was another equity/fixed-income CEF coming up on its heels and once the BlackRock Capital Allocation fund (BCAT) got a 124% distribution raise in 2024, it was off to-the-races. The result has been one of the most diverging fortunes for both funds that I have ever seen in CEFs.
BlackRock Capital Allocation Term Trust remains a hold, with its high yield supported by recent tech-driven rallies but unsustainable over the long term. BCAT's option writing and concentrated portfolio have fueled outperformance, but these strategies cap long-term growth and risk NAV erosion as payouts exceed earnings. Current distributions are largely return of capital, with 91% YTD, signaling NAV drawdown and limited sustainability if market momentum fades or interest rates rise.
NEW YORK--(BUSINESS WIRE)--BlackRock Provides Update on Closed-End Fund Discount Management Programs.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCAT and any ticker you trade — then tracks every position and per-strategy win rate.
